Drugs / mRNA plus Lysate-loaded Dendritic Cell Vaccine
mRNA plus Lysate-loaded Dendritic Cell Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05799612 | Mar → Nov 2024 | angiosarcoma | M.D. Anderson Cancer Center | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA plus Lysate-loaded Dendritic Cell Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05799612 ↗ |
| Modality | Vaccine | “mRNA vaccine” NCT05799612 ↗ |
| Route | Intravenous | “Given by IV (vein)” NCT05799612 ↗ |